Beyond Borders: Navigating the Corporate Practice of Medicine (CPOM) in a Multi-State Healthcare Landscape, 2025-2026

2026-06-17

The Corporate Practice of Medicine (CPOM) doctrine continues to be a formidable regulatory challenge for healthcare entities seeking to scale nationally. Understanding its intricate, state-specific variations is paramount for telehealth platforms, multi-state practices, and investors aiming for compliant growth and operational integrity in 2025-2026. This deep dive provides actionable insights to navigate this complex legal landscape.

The healthcare landscape is rapidly evolving, driven by technological advancements, shifting patient expectations, and an increasingly dynamic investment environment. For telehealth founders, brick-and-mortar practices eyeing national expansion, and private equity firms investing in healthcare, the promise of scale is tempered by a pervasive regulatory challenge: the Corporate Practice of Medicine (CPOM) doctrine. In 2025-2026, CPOM remains not just a legal technicality but a critical determinant of business viability, dictating how medical services can be delivered, owned, and managed across state lines. Failing to navigate its nuances can result in severe penalties, operational shutdowns, and significant financial losses. This analysis delves deep into the CPOM labyrinth, offering a definitive guide for compliant growth.

> For more on this topic, see our analysis: [Navigating the Labyrinth: Telehealth Controlled Substance Prescribing in the 2025-2026 Regulatory Landscape](/blog/telehealth-controlled-substance-prescribing-2025).

The Enduring Principle of CPOM: A Historical Context

At its core, the CPOM doctrine generally prohibits corporations, or other non-physician-owned entities, from practicing medicine or employing physicians to practice medicine. Its historical roots are firmly planted in protecting the integrity of the physician-patient relationship. Originating in the early 20th century, the doctrine was designed to prevent commercial entities from interfering with a physician's independent medical judgment, thereby safeguarding patient welfare and maintaining professional ethical standards. The underlying fear was that profit motives might compromise clinical decisions, leading to substandard care or unnecessary procedures.

While the fundamental objective remains relevant, the application of CPOM has become incredibly complex, particularly as healthcare delivery models innovate and span multiple jurisdictions. It's not a federal law but rather a collection of state-specific statutes, regulations, and judicial interpretations, creating a highly fragmented and often contradictory legal environment.

> For more on this topic, see our analysis: [The Broadening Net: Recent Federal Enforcement Signals Heightened Scrutiny Across Healthcare Operations](/blog/federal-enforcement-heightened-scrutiny-healthcare).

Core Tenets and Modern Interpretations

The prohibition against CPOM primarily targets several key areas:

Physician Employment: Many states prohibit or severely restrict the direct employment of physicians by non-medical corporations. This means a lay corporation generally cannot hire a physician to provide medical services and bill for those services under the corporate entity's name.
Ownership and Control: Non-physicians are often barred from owning or controlling medical practices, ensuring that clinical decision-making authority rests solely with licensed medical professionals.
Fee-Splitting: The doctrine often includes prohibitions against fee-splitting, where a non-licensed entity shares in professional fees generated by a physician. This is intended to prevent improper financial inducements that could influence referrals or treatment decisions.

These tenets impact virtually every aspect of a healthcare business, from corporate structuring and physician compensation to branding and marketing. The critical distinction lies in separating the business operations of a medical practice from the clinical practice of medicine itself.

The State-Specific Patchwork: Key Jurisdictions to Watch

The greatest challenge in CPOM compliance lies in its dramatic state-by-state variations. What is permissible in one state can be a felony in another. Multi-state operators must conduct a meticulous jurisdictional analysis for every state where they operate or intend to operate.

Strict CPOM States

These states maintain robust prohibitions against CPOM and enforce them actively:

California: One of the most stringent CPOM states. California Business and Professions Code Section 2400 explicitly states that corporations are prohibited from practicing medicine. This includes employing physicians and even dictating certain administrative aspects that might infringe on professional judgment. California prohibits fee-splitting and dictates that medical practices must be owned by licensed physicians or medical professional corporations. For multi-state telehealth, this often necessitates a separate California professional medical corporation that employs its own physicians and contracts with a management services organization (MSO) under strict terms.
Texas: The Texas Medical Practice Act (Texas Occupations Code § 151.001 et seq.) prohibits non-physicians from employing physicians to provide medical services. While Texas does allow for some limited exceptions, the general rule is strict. Physician services must be rendered by a physician or a professional association/corporation wholly owned by physicians. The state actively scrutinizes arrangements that appear to grant undue influence or control to lay entities.
New York: New York Education Law and judicial interpretations restrict the corporate practice of the professions, including medicine. Professional corporations (PCs) must be owned and controlled by licensed professionals. Non-physician entities cannot employ physicians or control medical decisions. New York is also vigilant against improper fee-splitting arrangements.

Moderate CPOM States

These states have CPOM doctrines but may offer certain exceptions or clearer guidance for compliant structures:

Florida: While generally adhering to CPOM, Florida's Medical Clinical Laboratory Act (MCLFA) has specific provisions, and the state has historically been more amenable to MSO models, provided the MSO does not exercise control over clinical decisions and charges fair market value for its services. The Florida Board of Medicine scrutinizes arrangements for signs of undue influence or prohibited fee-splitting.
Colorado: Colorado law generally prohibits the corporate practice of medicine, but its interpretations have provided more clarity regarding the permissible scope of management service agreements. The Colorado Medical Board has issued guidance on what constitutes the